Health News (Reuters)

FDA approves first ALS treatment in more than two decades

(Reuters) - The Food and Drug Administration on Friday approved Mitsubishi Tanabe Pharma Corp's treatment for fatal neurological disorder amyotrophic lateral sclerosis (ALS), marking the first such U.S. regulatory approval in more than two decades.

Many eye care providers may not catch macular degeneration

(Reuters Health) - Primary care optometrists and ophthalmologists may sometimes fail to detect age-related macular degeneration, the most common cause of vision impairment in the elderly, a recent U.S. study suggests.

Runners battling infections are less likely to finish a race

(Reuters Health) - Light, localized illnesses like a runny nose may not affect distance runners’ performance, but racing within days of an acute, systemic infection raises the odds of never finishing, researchers say.

Iowa Supreme Court blocks portion of 20 week abortion ban

(Reuters) - The Iowa Supreme Court on Friday granted an emergency temporary injunction halting a portion of a 20-week abortion ban that was signed into law by Republican Governor Terry Branstad just hours earlier.

Can herbal remedies help kids with gastrointestinal issues?

(Reuters Health) - Many parents of children with debilitating gastrointestinal disorders may be frustrated by the lack of good treatment options and tempted to try herbal remedies at home, but a new study suggests they should proceed with caution.

Republican health bill stirs fear in opioid-wracked West Virginia

(Reuters) - Debra Bright said she battled for years with mental illness and addiction to pain pills and other drugs that were all too easy to find where she lives in West Virginia, one of the states hardest hit by the country's opiate epidemic.

Good heart health extends the ‘golden years’

People with better heart health during young adulthood and middle age end up living longer and spending fewer years later in life with any kind of chronic disease, according to new research.

GSK 'real world' drug test has second success in asthma

LONDON (Reuters) - GlaxoSmithKline notched up a second win for its pioneering "real world" approach to testing new drugs on Friday as its inhaled medicine Breo proved significantly better than standard care in helping people with asthma. The success of the 4,233-patient trial, which tested Breo in day-to-day practice across the town of Salford in northern England, follows a similar win for the medicine in chronic obstructive pulmonary disease (COPD) a year ago. The study showed the drug, w

Australia wins landmark WTO tobacco packaging case - Bloomberg

GENEVA/LONDON (Reuters) - A landmark Australian law on restrictive tobacco packaging has been upheld at the World Trade Organization after a five-year legal battle, Bloomberg news reported on Thursday, citing two people familiar with the situation.

J&J ordered to pay $110 million in U.S. talc-powder trial

(Reuters) - Johnson & Johnson on Thursday was ordered by a Missouri jury to pay over $110 million to a Virginia woman who says she developed ovarian cancer after decades of using of its talc-based products for feminine hygiene.

House Republicans repeal Obamacare, hurdles await in U.S. Senate

WASHINGTON (Reuters) - The U.S. House of Representatives on Thursday narrowly approved a bill to repeal Obamacare, handing Republican President Donald Trump a victory that could prove short-lived as the healthcare legislation heads into a likely tough battle in the Senate.

Health insurers focused on 2018 unknowns for Obamacare market

NEW YORK (Reuters) - While attention is focused on Republicans' fight to pass a bill to repeal Obamacare starting in 2019, health insurers are busy struggling with decisions they need to make now about how to price premiums and what markets they can afford to be in next year.

Eating pure oats may be okay for celiac sufferers

(Reuters Health) - People with celiac disease have to avoid most grains, but oats may be an exception that’s safe, according to a recent research review, so long as the oats are uncontaminated by traces of other grains.

Novartis, Roche back French gene therapy start-up Vivet

(Reuters) - French gene therapy start-up Vivet Therapeutics said on Thursday it had raised 37.5 million euros ($41 million) in an initial financing round, with backing from the venture arms of Swiss drugmakers Novartis and Roche.

U.S. prescription drug spending as high as $610 billion by 2021: report

(Reuters) - Spending on prescription medicines in the United States will increase 4-7 percent through 2021, reaching $580 billion to $610 billion, according to a report released by QuintilesIMS Holding on Thursday that lowered its prior long-term forecast.

WHO to help bring cheap biosimilar cancer drugs to poor

LONDON (Reuters) - The World Health Organization (WHO) is to launch a pilot project this year to assess cheap copies of expensive biotech cancer drugs in a bid to make such medicines more widely available in poorer countries.